Skip to main content

Find Clinical Trials

Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

851 public trials 186 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Recruiting

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT06533332

Conditions: Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +31 more
Locations: Macquarie University Health Ryde, New South Wales, Australia

The Kinghorn Cancer Center Sydney, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Cancer Research SA Adelaide, South Australia, Australia

View Trial Details

Recruiting

Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal Ablation

NCT07601464

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: IRCCS Policlinico di Sant'Orsola Bologna, Emilia-Romagna, Italy

View Trial Details

Recruiting

China Metastatic Liver Cancer Clinical Registry Cohort Database

NCT07602504

Conditions: Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Neoplasms, +14 more
Locations: The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China

The First Affiliated Hospital of USTC (Anhui Provincial Hospital) Hefei, Anhui, China

The Affiliated Hospital of Qingdao University Qingdao, Shandong, China

View Trial Details

Recruiting

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

NCT06263088

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +40 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

NCT05184790

Conditions: Arrhythmias, Cardiac, Bone Diseases, Bone Neoplasms, +50 more
Locations: Royal North Shore Hospital Saint Leonards, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Alfred Health Melbourne, Victoria, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Recruiting

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

NCT05169177

Conditions: Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, +4 more
Locations: Calvary Mater Newcastle Hospital Waratah, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Recruiting

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

NCT07224464

Conditions: Adenocarcinoma, Adnexal Diseases, Body Temperature Changes, +49 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Recruiting

Brodalumab in the Treatment of Immune-Related Adverse Events

NCT06673329

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +77 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Recruiting

Computer Guided Microwave Liver Ablation

NCT07226869

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dartmouth HItchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Recruiting

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NCT06794073

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details